Welldoc Wins ‘Best Overall Digital Health Company’ Award for Third Consecutive Year
COLUMBIA, Md.–Welldoc®, a digital health leader revolutionizing AI-driven cardiometabolic care, has been selected as the winner of the ‘Best Overall Digital Health Company’ award for the third consecutive year in the MedTech Breakthrough Awards. The annual awards program, conducted by MedTech Breakthrough, recognizes top companies, technologies, and products in the global digital health and medical technology market.
This marks the fourth time MedTech Breakthrough has recognized Welldoc for its leadership and innovation in the digital health industry. Welldoc’s comprehensive AI-driven platform delivers flexible, multi-condition digital coaching across diabetes, hypertension, heart failure, prediabetes, and weight management, including GLP-1 support. The company enables health plans, health systems, and employers to extend traditional care models and partners with pharmaceutical and medical device industry leaders to develop first-in-class, regulated combination products.
“Precise personalization is not the future – it’s the present, and Welldoc meets this need with our digital-first solutions focused on whole-person health,” said Kevin McRaith, President and CEO of Welldoc. “By proactively anticipating evolving AI guidelines, we are driving innovation and ensuring safety, accuracy, and adaptability in this rapidly evolving field.”
The MedTech Breakthrough Awards program celebrates excellence, innovation, and meaningful progress in various categories, including Telehealth, Clinical Administration, and Patient Engagement. This year’s program attracted nominations from over 18 countries, showcasing the global impact and momentum of the digital healthcare industry.
“Welldoc delivers a tailored solution for unique needs, no matter where an individual is on their journey,” said Steve Johansson, Managing Director of MedTech Breakthrough. “With personalized insights at their fingertips, individuals are better equipped to manage their health independently – enabling improved long-term outcomes.”
Welldoc’s leadership is grounded in clinical rigor and regulatory expertise, demonstrated by over 90 clinical publications, 11 FDA 510(k) clearances for diabetes functionality, and 54 novel patents for their first-in-class AI technology. The company’s AI correlates insights across a broad spectrum of health data, offering actionable predictive capabilities to support improved health outcomes across multiple conditions.
About Welldoc Welldoc® is a digital health leader revolutionizing cardiometabolic care by integrating personalized, real-time, and actionable insights into the daily lives of individuals living with cardiometabolic conditions. The company’s comprehensive digital health platform provides AI-powered digital coaching across various health conditions and has achieved significant regulatory clearances and industry recognition.
For more information, visit www.welldoc.com.
